SRAVANI REDDY GANTLA's most recent trade in Oxygenta Pharmaceutical Ltd. was a Disposal of 1,979,340 Equity Shares done at an average price of Rs. 21 . Disclosure was reported to the exchange on April 24, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
SRAVANI REDDY GANTLA's has made SAST transactions in Oxygenta Pharmaceutical Ltd. recently where a Disposal of 1,979,340 shares done . Disclosure was reported to the exchange on April 23, 2025.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oxygenta Pharma | Sravani Reddy Gantla | Other | Disposal | 30 Apr 2025 | 1,979,340 | 543,000 (1.47%) | 5.35% | - | 16 Apr 2025 16 Apr 2025 |
SAST (29(2)) | - | Others | |
Oxygenta Pharma | Sravani Reddy Gantla | Other | Disposal | 30 Apr 2025 | 1,979,340 | 2,507,660 (6.78%) | 5.35% | - | 16 Apr 2025 16 Apr 2025 |
SAST (29(2)) | - | Others | |
Oxygenta Pharma | SRAVANI REDDY GANTLA | Director | Disposal | 24 Apr 2025 | 1,979,340 | 2,507,660 (6.78%) | 5.35% | 21 | 41,566,140 | 16 Apr 2024 16 Apr 2024 |
Insider Trading | Equity Shares | Others |